Inhibition of HSP90 by geldanamycin analogue 17-allylamino-17-demethoxy-geldanamycin (17-AAG) attenuates LPS-induced increase in retinal NF-κB activity, leading to suppression of inflammation in LPS-induced uveitis [42]. The gene discussed is NFKB1; the disease is uveitis.